Wendelin Maners

Wendelin Maners has held various high-level positions throughout their career. Wendelin started at Wells Fargo Securities, LLC in 2000 as Vice President and Head of Healthcare Investment Banking. In 2003, they joined Boston Scientific as Vice President of Business Development and Strategy, where they worked until 2011. From 2010 to 2011, they also worked as a Consultant at Medical Device Strategy and M&A.

In 2011, Wendelin joined CSA Medical Inc as Vice President of Emerging Therapies, responsible for managing market development and clinical training programs. Wendelin stayed with the company until 2014 and then moved on to MRI Interventions, Inc. as Vice President of Sales Marketing and Clinical Operations. During their tenure at MRI Interventions, they led the commercial operations, achieving significant revenue and procedural growth.

Back at CSA Medical Inc in 2018, Wendelin served as Chief Commercial Officer and President of truFreeze before becoming President and CEO in December 2019. Wendelin currently holds this position.

From 1983 to 1985, Wendelin Maners attended the USC Marshall School of Business. During this time, they pursued studies in the field of Finance. However, no specific degree is mentioned in the provided information.